Both severe COVID-19 and PTSD were associated with upregulated PAI-1, a negative tPA regulator, indicating that targeting this protein may be therapeutic for both diseases (Cesari et al., 2010; Idell et al., 2017; Bouarab et al., 2021). This evidence concerns the gene SERPINE1 and COVID-19.